论文部分内容阅读
1989年9月在日本东京举行的国际非甲非乙型肝炎(NANBH)及经血传播性疾病会议,对非肠道传播的NANBH及其主要致病病毒,被分别命名为丙型肝炎(HC)和丙型肝炎病毒(HCV),国外报道了HCV克隆的成功及相应的血清丙型肝炎病毒抗体(抗-HCV)诊断方法的建立,为HC的诊断提供了依据。近年来,输血后乙型肝炎(PT-HB)发病率明显降低,输血后丙型肝炎(PT-HC)相对增多。为了解HCV感染与输血的关系,现将我院收治的输血后的肝炎患者,进行血清抗-HCV的检测结果,报告如下。 材 料 和 方 法 一、病例选择:本组病例为我院1991年11月～1992年9月门诊与住院患者,男135例,女81例,平均年龄44.5岁(4～82岁);共216例,其中112例系因肝、脾、胃、胆囊、外伤,肾脏及心脏换瓣等原因行手术者及血液病,恶性肿瘤等慢性疾病的输血或新鲜冰冻血浆者,发病至采血时间数周至2年。 二、诊断标准:1.既往无肝炎病史,输血或输
The International Non-A Non-A Hepatitis B (NANBH) and Meniscus Disorders Conference held in Tokyo, Japan, in September 1989, was named Hepatitis C (HC) for parenteral transmission of NANBH and its major causative virus, And hepatitis C virus (HCV). The success of HCV cloning and the establishment of corresponding serum HCV antibody (anti-HCV) diagnosis in foreign countries were reported, which provided a basis for the diagnosis of HC. In recent years, the incidence of post-transfusion hepatitis B (PT-HB) was significantly lower after transfusion of hepatitis C (PT-HC) relative increase. In order to understand the relationship between HCV infection and blood transfusion, now in our hospital transfusion of hepatitis patients, serum anti-HCV test results are as follows. Materials and methods A case selection: The patients in our hospital from November 1991 to September 1992 outpatient and inpatient, 135 males and 81 females, average age 44.5 years (4 to 82 years); a total of 216 cases , Of which 112 cases were due to liver, spleen, stomach, gallbladder, trauma, kidney and heart valve replacement and other causes of surgery and blood diseases, malignant tumors and other chronic diseases, blood transfusions or fresh frozen plasma, the incidence of blood sampling time to weeks 2 year. Second, the diagnostic criteria: 1. Past no history of hepatitis, blood transfusion or lose